Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial - Concepedia

Concepedia

Publication | Open Access

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial

DOI Full Paper Access

130

Citations

26

References

2008

Year

Lawrence J. Singerman, Harvey Masonson, M. Patel, Anthony P. Adamis, Ronald Buggage, Emma Cunningham, Mauro Goldbaum, Barrett Katz, David E. Guyer

British Journal of Ophthalmology

Abstract

The 3-year safety profile of pegaptanib sodium was favourable in patients with NV-AMD.

References

	Year	Citations

Page 1